MaxCyte Stock

MaxCyte Capital Intensity

The Capital Intensity Ratio of MaxCyte (MXCT) as of Aug 6, 2026 is 619.95 %. In the previous year, Capital Intensity Ratio was 649.76 % — a change of -4.59% (lower).

Capital Intensity

619.95 %

YoY

-4.59%

Last updated:

Capital Intensity Ratio of MaxCyte is 2026 619.95 % . Capital Intensity Ratio of MaxCyte was 2025 649.76 % . It decreases by -4.59% lower compared to the previous year.
Access this data via the Eulerpool API

MaxCyte Stock analysis

What does MaxCyte do? MaxCyte Inc is a US biotechnology company specializing in the development of platform-based technologies for the next generation of gene and cell therapies. They offer integrated platform technology for drug manufacturing, research, and development. Their proprietary platform technology, Flow ElectroporationTM, allows for efficient transduction of a variety of cells, making it a valuable tool for the production of CAR-T cell therapies. They also offer services for lentiviral production and customized gene therapy production. MaxCyte has secured $50 million in funding for expansion and has formed important partnerships in the industry. They are a leading player in the development of innovative technologies for gene and cell therapy products. MaxCyte is one of the most popular companies on Eulerpool.

Frequently Asked Questions about MaxCyte stock

Capital Intensity Ratio of MaxCyte is 619.95 % in 2026.

Capital Intensity Ratio of MaxCyte changed from 649.76 % to 619.95 %, representing a -4.59% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Capital Intensity Ratio MaxCyte since 2006 – with annual values, charts, and detailed analysis.

Capital intensity measures the amount of assets needed to generate each unit of revenue. Lower ratios indicate asset-light business models.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Capital Intensity Ratio's MaxCyte with sector peers and the industry average to assess whether it is attractive.

To evaluate Capital Intensity Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Capital Intensity Ratio.

Access this data via the Eulerpool API

Profitability — MaxCyte

All Key Metrics — MaxCyte